Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
nab-paclitaxel and carboplatin in castration-resistant prostate cancer
NCT04148885Phase 2Unknown
- Sponsor
- Shanghai General Hospital
- Start
- Nov 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of paclitaxel in prostate cancer (PCa), sponsored by Shanghai General Hospital. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04148885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04148885.